Improvement of small airway deposition of corticosteroids by smart nebulisation

B. Müllinger (Gauting, Germany), J. Schick (Gauting, Germany), G. Burgess (Chippenham, United Kingdom), S. Snape (Cambridge, United Kingdom)

Source: International Congress 2018 – Asthma and drugs
Session: Asthma and drugs
Session type: Thematic Poster
Number: 3983
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Müllinger (Gauting, Germany), J. Schick (Gauting, Germany), G. Burgess (Chippenham, United Kingdom), S. Snape (Cambridge, United Kingdom). Improvement of small airway deposition of corticosteroids by smart nebulisation. 3983

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011



Adherence to inhaled steroids treatment using smart nebulisers in severe asthmatics
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004

Assessment of technique in use of inhalation devices in bronchial asthma
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Are extra-fine particles from dry powder inhalers likely to improve lung deposition?
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Coupling of noninvasive mechanical ventilation and nebulization during asthma exacerbations: higher amount of aerosol deposition into the airways or effective mechanical brochodilation due to positive pressure?
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009

Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014


In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distribution
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Are ultrafine particle inhalers, better for patients with small airway involvement?
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014


Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017



Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

Reproducibility of inhaler use and pulmonary drug deposition in COPD
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Ciclesonide improves measures of small airway involvement in asthma
Source: Eur Respir J 2008; 31: 1213-1220
Year: 2008



The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014


Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009

Particle size matters: diagnostics and treatment of small airways involvement in asthma
Source: Eur Respir J 2011; 37: 532-540
Year: 2011



Efficacy of the device in targeting tiotropium to the small airways in COPD
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017



Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017